Locations:
Search IconSearch

AUA 2017 – Sunday, May 14

Please join our staff as we participate or present in the following presentations at the 2017 AUA Annual Meeting

17-URL-800 AUA 17 1_CQD Header

MP49-04: Excised Parenchymal Mass and Devascularized Parenchymal Mass Associated with Partial Nephrectomy: Impact on Functional Recovery
7 – 9 a.m.
Presenting Author: Chalairat Suk-Ouichai
Location: BCEC: Room 252

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

MP49-10: Ischemia and Functional Recovery from Partial Nephrectomy: Refined Perspectives
7 – 9 a.m.
Presenting Author: Chalairat Suk-Ouichai
Location: BCEC: Room 252

MP49-11: Renal Ischemia and Volume Loss Have a Compounding Effect on Acute Renal Dysfunction after Partial Nephrectomy
7 – 9 a.m.
Presenting Author: Julien Dagenais, MD
Location: BCEC: Room 252

MP49-17: Robot-assisted partial nephrectomy for selected renal mass using off-clamp approach offered renal functional advantage over on-clamp
7 – 9 a.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 252

044IC: AUA Guidelines 2017: Evaluation and Management of Localized Renal Mass
7:30 – 9:30 a.m.
Course Director: Steven Campbell, MD
Location: BCEC 258B

MP55-04: Perinephric versus sinus fat invasion in pT3a tumors managed by partial nephrectomy
9:30 – 11:30 a.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 253AB

MP56-12: Concerns of Female Peyronie’s Disease Partners: A Narrative Analysis
1 – 3 p.m.
Presenting Author: Barbara Chubak, MD
Location: BCEC: Room 151

MP59-15: Long−term Outcomes After Renal Cancer Surgery: Predictors of Chronic Kidney Disease and Non−Renal Cancer Mortality
1 – 3 p.m.
Presenting Author: Joseph Zabell, MD
Location: BCEC: Room 160

MP59-16: Vascularized Parenchymal Mass Preservation with Partial Nephrectomy: Functional Impact and Predictive Factors
1 – 3 p.m.
Presenting Author: Jitao Wu, MD
Location: BCEC: Room 160

The Reproductive Risks of Chemo and Radiation therapy for Boys: Lessons Learned from U.S. & Global Cohorts (and data needs for future)
1:20 – 1:35 p.m.
Speaker: Daniel Greene, MD
Location: BCEC: Room 204

Advertisement

Single-site robotic urologic surgery on horizon for clinical use
1:23 – 1:36 p.m.
Speaker: Jihad Kaouk, MD, FACS
Location: Westin Waterfront: Marina Ballroom

Second Opinion Cases: Renal Hilar Mass
1:30 – 2 p.m.
Panelist: Georges-Pascal Haber, MD, PhD
Location: BCEC: Ballroom West

Prostate Cancer – New Markers, Imaging Modalities for Better Diagnosis
2:05 – 3 p.m.
Moderator: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A

Incorporating mMRI in the Diagnostic Decision Making for Significant Cancer
2:15 – 2:30 p.m.
Speaker: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A

Panel Discussion on Clinical Cases: What is Your Choice of Treatment
2:30 – 3 p.m.
Moderator: Andrew J. Stephenson, MD
Location: Westin Grand Ballroom A

MP63: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Incontinence: Evaluation (Urodynamic Testing)
3:30 – 5:30 p.m.
Poster Session Moderator: Courtenay K. Moore, MD
Location: BCEC: Room 153

MP67-09: Surveillance strategy and outcome after partial nephrectomy
3:30 – 5:30 p.m.
Presenting Author: Pascal Mouracade, MD, PhD
Location: BCEC: Room 252

Interstitial Cystitis
4:05 – 4:55 p.m.
Moderator: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A

Management of Interstitial Cystitis – An Evidence Based Approach Utilizing the AUA Guidelines
4:15 – 4:25 p.m.
Speaker: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A

Panel Discussion on Clinical Cases: How do you treat this patient? Differences in approaches?
4:25 – 4:55 p.m.
Moderator: Howard Goldman, MD, FACS
Location: Westin Grand Ballroom A

Advertisement

Please note: Presentations listed as of May 8, 2017. Date and locations are subject to change.

Advertisement

Related Articles

CT scan of female patient bladder cancer
November 26, 2024/Urology & Nephrology/Urology
Use of Interim Imaging To Preserve Eligibility for Vaginal-Sparing Cystectomy

Retrospective study evaluates clinical upstaging during neoadjuvant treatment

Microscopic view of bladder cancer with variant histology
November 19, 2024/Urology & Nephrology/Urology
Nonmuscle Invasive Bladder Cancer With Variant Histology: When To Consider a Bladder-Sparing Approach

Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy

Single-port robot docked in the operating room
November 12, 2024/Urology & Nephrology/Urology
Single-Port Pyeloplasty in a Pediatric Patient: A Novel Surgical Technique

Revolutionizing pediatric urology with a new, less invasive approach

Physician smiles at patient in a preoperative setting
September 12, 2024/Urology & Nephrology/Urology
Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

Surgeons in the operating room with the single-port robot
Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Photo of Dr. Bajic
Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Illustration of red blood cells in motion
Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

UTI bacteria and artificial intelligence
AI Algorithms Accurately Predict Antibiotic Resistance in UTI

Up to 3 days faster than waiting for urine culture results

Ad